Scott A. Holmes

2017 - Keryx Biopharmaceuticals

In 2017, Scott A. Holmes earned a total compensation of $1.2M as Chief Financial Officer and Treasurer at Keryx Biopharmaceuticals, a 27% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$142,690
Option Awards$386,042
Salary$373,969
Stock Awards$269,588
Other$3,824
Total$1,176,113

Holmes received $386K in option awards, accounting for 33% of the total pay in 2017.

Holmes also received $142.7K in non-equity incentive plan, $374K in salary, $269.6K in stock awards and $3.8K in other compensation.

Rankings

In 2017, Scott A. Holmes' compensation ranked 8,205th out of 14,666 executives tracked by ExecPay. In other words, Holmes earned more than 44.1% of executives.

ClassificationRankingPercentile
All
8,205
out of 14,666
44th
Division
Manufacturing
3,096
out of 5,768
46th
Major group
Chemicals And Allied Products
1,019
out of 2,074
51st
Industry group
Drugs
801
out of 1,730
54th
Industry
Pharmaceutical Preparations
628
out of 1,329
53rd
Source: SEC filing on May 31, 2018.

Holmes' colleagues

We found four more compensation records of executives who worked with Scott A. Holmes at Keryx Biopharmaceuticals in 2017.

2017

Gregory Madison

Keryx Biopharmaceuticals

Chief Executive Officer

2017

Christine Carberry

Keryx Biopharmaceuticals

Chief Operating Officer

2017

John Neylan

Keryx Biopharmaceuticals

Chief Medical Officer

2017

Brian Adams

Keryx Biopharmaceuticals

General Counsel

You may also like